![Jill Howe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 27 540 $ in data 31/07/2026
Jill Ann Howe is currently Director at MUSC Foundation for Research Development, Independent Director at Biora Therapeutics, Inc. since 2021, Chief Financial Officer at Lineage Cell Therapeutics, Inc. since 2022, and Chief Financial Officer at Asterias Biotherapeutics, Inc. Former positions include Director at Codagenix, Inc. from 2021 to 2025, Finance Director & Controller at Amplyx Pharmaceuticals, Inc. from 2016 to 2017, Finance Director & Controller at Somaxon Pharmaceuticals, Inc. from 2006 to 2013, Finance Director & Controller at Receptos LLC from 2013 to 2016, Chief Financial Officer at DTx Pharma, Inc. from 2021 to 2022, and Treasurer & VP-Finance at Gossamer Bio, Inc. from 2018 to 2021.
Education includes undergraduate studies at San Diego State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 25.500 ( 0,01% ) | 27 540 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/11/2021 |
| LINEAGE CELL THERAPEUTICS, INC. | Direttore Finanziario/CFO | 14/11/2022 |
| ASTERIAS BIOTHERAPEUTICS INC | Direttore Finanziario/CFO | - |
MUSC Foundation for Research Development | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Codagenix, Inc.
 Codagenix, Inc. Medical/Nursing ServicesHealth Services Provides platform technology to construct viral vaccines against multiple targets. | Direttore/Membro del Consiglio | 01/03/2025 |
DTx Pharma, Inc.
 DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Direttore Finanziario/CFO | 01/07/2022 |
| GOSSAMER BIO, INC. | Treasurer | 01/06/2021 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Direttore Finanziario/CFO | 01/12/2017 |
| RECEPTOS INC | Direttore Finanziario/CFO | 01/03/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MUSC Foundation for Research Development | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Codagenix, Inc.
Codagenix, Inc. Medical/Nursing ServicesHealth Services Provides platform technology to construct viral vaccines against multiple targets. | Health Services |
DTx Pharma, Inc.
DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
